ARCHIVES

Phase III Kyprolis Trial Fails OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

NCI Initiative: Start With Mechanism, Then answer The Many Questions, Klauser Says to Advisors

November 29, 1996

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

May 31, 1991

Appropriations: NIH Professional Needs Budget Gains Attention

March 14, 1997